In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Teva Neuroscience Inc.

Division of Teva Pharmaceutical Industries Ltd.

Latest From Teva Neuroscience Inc.

Rx Drug Promotion Risks: Value Claims, Getting Close To Patients

Comparative claims to distinguish a product are triggering FDA enforcement letters; companies also face risks when interacting more with patients.

BioPharmaceutical United States

Specialty Rx Use Higher In Exchanges Than Commercial Plans – Express Scripts

Express Scripts analysis of pharmacy claims from the first two months of Affordable Care Act exchange plan operations show members of those plans are prescribed specialty drugs 47% more often than members of commercial plans.

BioPharmaceutical United States

Biosimilar Patent Strategy: Follow-Ons May Target Secondary, Third Party Patents

Initial applicants could establish solid precedents in courts and at FDA – to the benefit of subsequent competitors.

BioPharmaceutical United States

FDA Enforcement Letters On Rx Drug Promotions Plummet In 2013

OPDP Director Tom Abrams cautions against reading into the “snapshot.”

BioPharmaceutical United States
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
  • Therapeutic Areas
  • Neurology, Nervous System
  • Alias(es)
  • Teva Marion
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Teva Pharmaceutical Industries Ltd.
  • Senior Management
  • Larry Downey, CEO
  • Contact Info
  • Teva Neuroscience Inc.
    Phone: (816) 508-5000
    901 E. 104th Street
    Ste. 900
    Kansas City, MO 64131